Hosted by Offit Kurman and featuring Cannabis Practice Group attorneys and experts from outside the firm this monthly, hour-long webinar series addresses operational and legal issues affecting those in legalized cannabis industry.
The series is designed for applicants for, and operators of, legal cannabis businesses as well as business owners and service providers servicing the industry. Sign up here to receive email invitations to The Cannabusiness Key in your inbox.
Cannabinoid Clinical Research: The Current State of the Investigative Science in THC, CBD and Others
As CEO of Jabez Pharma Holdings, Inc. Steve Beagle addresses the topic of real investigative science going on in both the regulated and non-regulated areas of cannabinoid science. The continued loosening of restrictions from the FDA, in particular, presents some exciting opportunities to do research science on cannabinoids in humans, but at the same time, ongoing uncertainty and delays present major obstacles to broader market acceptance and expansion. Mr. Beagle will be explaining the current state of cannabinoid science and shedding light on the challenges that drug development companies face as they attempt to navigate this highly dynamic space and formulate drug dosages for the Rx, OTC and nutraceutical markets.
About Steven Beagle
Steven Beagle hasheld senior positions in the pharmaceutical sector for over thirty years. Prior to founding Jabez Pharma in the summer of 2018 he was Senior Director of MSN Pharmaceuticals from 2013-2017 where he headed North American marketing and sales of their API division. He has been credited for the exponential US growth that has now emerged from his work during that time period. Prior to this role, Steve headed publicly-traded Dr. Reddy’s CPS custom chemistry business from 2011 to 2013. Mr. Beagle possesses extensive experience in the pharmaceutical industry, holding key roles not only at MSN and Dr. Reddy’s but also at DSM, BASF, Rohner AG, American Cyanamid and Hovione. He holds a BS from the University of Connecticut and also studied at the Arnold and Marie Schwartz (Brooklyn) College of Pharmacy.
Speaker: Jason Klein, Attorney at Offit Kurman
Jason Klein is a business attorney who focuses on cannabis in tightly-regulated markets on the east coast. Working with direct and ancillary cannabis businesses since 2011, Mr. Klein has a long track record assisting his clients in successfully navigating challenging regulatory and business operating environments amid uncertainty in new marketplaces. Mr. Klein guides cannabis clients through every stage of the business life-cycle, from business formation to sale. Mr. Klein’s passion is structuring and negotiating all aspects of buy-side and sell-side M&A deals, including maneuvering through complicated compliance issues and applying traditional solutions to modern problems in ways that bring buyers and sellers together to complete their most important transactions.
Date: Friday, December 6th
Time: 12:00 – 1:00 PM EST